The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation

Journal of Immunology

Volumn 167, Issue 10, 2001, Pages 5874-5879

  Padigel, U M ^a   Perrin, P J ^a   Farrell, J P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; GENE EXPRESSION; HEALING; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION RESISTANCE; KNOCKOUT MOUSE; LEISHMANIASIS; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

EID: 0035889896     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.10.5874     Document Type: Article

References (46)

1. The regulation of immunity to Leishmania major
2. Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis
3. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity
4. CD40 ligand is required for protective cell-mediated immunity to Leishmania major
5. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection
6. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with Histoplasma capsulatum
7. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis
8. The CD40/CD40 ligand interaction is required for resistance to Toxoplasmic encephalitis
9. Differential effects of blockade of Cd28-b7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis
10. Limited role of CD28-mediated signals in T helper subset differentiation
11. Identification of an infective stage of Leishmania promastigotes
12. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major
13. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection
14. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes
15. Specific assays for cytokine production by T cells
16. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type I immune response
17. Recombinant interleukin 12 cures mice infected with Leishmania major
18. IL-12 is required to maintain a Th1 response during Leishmania major infection
19. + T cells during a Th2 response in Leishmania major infected mice
20. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: Evidence for a T cell-dependent, interferon γ-independent mechanism
21. Interleukin-4 receptor α-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection
22. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains
23. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease
24. + T cells resulting in a state of unresponsiveness to IL-12
25. Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major
26. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica
27. Therapeutic effect of anti-L3T4 monoclonal GK1.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice
28. IL-2 is necessary for progression of leishmaniasis in susceptible murine hosts
29. The induction of a protective response in Leishmania major-infected BALB/C mice with anti-CD40 mAb
30. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity
31. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction
32. + T cells during initiation of infection
33. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro
34. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with intracellular parasite Leishmania major
35. LeIF: A recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile
36. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity
37. - T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells
38. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation
39. - T cells by costimulation with B7-2 molecules
40. Regulation of interleukin-12 receptor β1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells
41. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway
42. CD28 costimulation accelerates IL-4 receptor sensitivity and IL-4-mediated Th2 differentiation
43. CD28 costimulation promotes the production of Th2 cytokines
44. CD40 and CD154 in cell-mediated immunity
45. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
46. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation